Meritage Group Lp adds McKesson Corporation (MCK) to its portfolio

McKesson Corporation (MCK) : Meritage Group Lp added new position in McKesson Corporation during the most recent quarter end. The investment management firm now holds 1,105,399 shares of McKesson Corporation which is valued at $183.4 Million , the company said in a statement filed on May 13, 2016 with the SEC.McKesson Corporation makes up approximately 5.13% of Meritage Group Lp’s portfolio.

Other Hedge Funds, Including , Symphony Asset Management reduced its stake in MCK by selling 11,374 shares or 67.24% in the most recent quarter. The Hedge Fund company now holds 5,542 shares of MCK which is valued at $919,584. McKesson Corporation makes up approx 0.18% of Symphony Asset Management’s portfolio. Pegasus Partners Ltd. added MCK to its portfolio by purchasing 2,958 company shares during the most recent quarter which is valued at $490,821. McKesson Corporation makes up approx 0.27% of Pegasus Partners Ltd.’s portfolio.Guardian Life Insurance Co Of America reduced its stake in MCK by selling 238 shares or 21.83% in the most recent quarter. The Hedge Fund company now holds 852 shares of MCK which is valued at $141,372. McKesson Corporation makes up approx 0.03% of Guardian Life Insurance Co Of America’s portfolio. Inverness Counsel Ny sold out all of its stake in MCK during the most recent quarter. The investment firm sold 2,546 shares of MCK which is valued $422,458.Geneva Advisors reduced its stake in MCK by selling 32,717 shares or 46.89% in the most recent quarter. The Hedge Fund company now holds 37,052 shares of MCK which is valued at $6.3 Million. McKesson Corporation makes up approx 0.13% of Geneva Advisors’s portfolio.

McKesson Corporation opened for trading at $182.94 and hit $185.5811 on the upside on Wednesday, eventually ending the session at $182.92, with a gain of 0.08% or 0.15 points. The heightened volatility saw the trading volume jump to 21,16,091 shares. Company has a market cap of $41,161 M.

On the company’s financial health, McKesson Corporation reported $2.44 EPS for the quarter, missing the analyst consensus estimate by $ -0.70 based on the information available during the earnings call on May 4, 2016. Analyst had a consensus of $3.14. The company had revenue of $46678.00 million for the quarter, compared to analysts expectations of $46810.61 million. The company’s revenue was up 3.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.94 EPS.

Many Wall Street Analysts have commented on McKesson Corporation. McKesson Corporation was Downgraded by Avondale to ” Mkt Perform” on May 5, 2016. McKesson Corporation was Downgraded by Standpoint Research to ” Hold” on Apr 26, 2016. Avondale Initiated McKesson Corporation on Apr 19, 2016 to “Mkt Outperform”, Price Target of the shares are set at $203.

McKesson Corporation (McKesson) is engaged in delivering pharmaceuticals medical supplies and healthcare information technology. The Company operates through two business segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment and health and beauty care products across North America and internationally. The Distribution Solutions segment provides pharmaceutical solutions for biotech and pharmaceutical manufacturers and practice management technology clinical support and business solutions to oncology and other specialty practices operating in the community setting. The Technology Solutions segment delivers clinical patient care financial supply chain and strategic management software solutions as well as connectivity outsourcing and other services including remote hosting and managed services to healthcare organizations.

Leave a Reply

McKesson Corporation - Is it time to Sell?

Top Brokerage Firms are advising their investors on McKesson Corporation. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.